e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Quality management in lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Should resection rate increase when PET-CT use increases? An analysis of PET-CT use in large UK lung cancer network 2011 - 2013
Matthew Evison (Manchester, United Kingdom), Haval Balata, Evison Matthew, Julie Morris, Haider Al-Najjar, Phil Barber, Philip Crosbie, Richard Booton
Source:
International Congress 2015 – Quality management in lung cancer
Session:
Quality management in lung cancer
Session type:
Thematic Poster Session
Number:
4224
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Matthew Evison (Manchester, United Kingdom), Haval Balata, Evison Matthew, Julie Morris, Haider Al-Najjar, Phil Barber, Philip Crosbie, Richard Booton. Should resection rate increase when PET-CT use increases? An analysis of PET-CT use in large UK lung cancer network 2011 - 2013. Eur Respir J 2015; 46: Suppl. 59, 4224
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Is there equitable access to PET-CT for lung cancer patients across a large UK cancer network; a retrospective study of 4597 patients
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
Analysis of PET-CT use across a UK cancer network: Are we adhering to NICE guidelines?
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
Completion pneumonectomy for lung cancer relapse after surgery- What is a real benefit?
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
Should CT-guided biopsy for suspected lung cancer be delayed pending PET/CT results?
Source: International Congress 2016 – Transbronchial diagnostics: from ILD to pheripheral lesions
Year: 2016
Reducing the rate of emergency presentation in lung cancer
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
Impact of PET scan on staging and management of lung cancer patients in Indian scenario
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013
Number of procedures and time needed to diagnose lung cancer: Being right the first time
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015
Pneumothoraces in CT guided lung biopsies – Are we too cautious?
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016
Incidental findings on PET-CT scans; how they are managed and how they impact on the lung cancer pathway
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Added value of EUS-B to EBUS for lung cancer staging
Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology
Year: 2015
Reduced perioperative mortality after centralization of lung cancer surgery
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
Segmentectomy for second lung cancer after lobectomy
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
Lung cancer revisited – CT scan and bronchoscopy concordance after treatment
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016
Should preoperative FDG uptake on PET/CT guide postoperative surveillance in surgical non-small cell lung cancer (NSCLC)
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016
Does the type of N1 state different survival
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016
A survey of outcome of CT guided lung biopsies in a tertiary centre
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013
Should all lung cancer patients requiring pathological nodal staging undergo PET-CT first?
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Improving survival for NSCLC patients in the national lung cancer audit
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
Validating an EBUS service provided by a group of operators with different levels of experience
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016
Electrospray-mediated local chemotherapy of lung carcinoma in mice
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept